期刊文献+

四氢生物蝶呤对大鼠急性心肌缺血再灌注损伤的保护作用及其机制研究 被引量:2

Protection of tetrahydrobiopterin against acute myocardial ischemia-reperfusion injury in rat and its mechanism
原文传递
导出
摘要 目的研究四氢生物蝶呤对大鼠急性心肌缺血再灌注损伤的保护作用,并探讨其作用机制。方法 Wistar大鼠随机分为对照组、假手术组、模型组及四氢生物蝶呤5、10 mg/kg组,每组10只。结扎左冠状动脉前降支,制备急性心肌缺血再灌注损伤模型。对照组、假手术组和模型组均ig生理盐水2 mL,四氢生物蝶呤组ig四氢生物蝶呤5、10 mg/kg。1次/d,连续给药14 d。导管法测定血流动力学指标:左心室舒张最大速率(-dp/dtmax)、左心室舒张期末压(LVEDP)、左室开始收缩至左室内压上升速率峰值时间(Tau);ELISA法测定血浆脑钠素(BNP)活性;按试剂盒说明测定心肌一氧化氮合酶(eNOS)活性、NO生成量;染色法测定心肌梗死面积,计算心肌梗死程度;免疫组化法测定β3水平。结果与模型组比较,四氢生物蝶呤5、10 mg/kg组-dp/dtmax显著增高,LVEDP显著降低,Tau明显缩短,差异均具有统计学意义(P<0.05、0.01);血浆BNP显著下降,eNOS活性、NO生成量均显著升高(P<0.01);心肌梗死面积更小,心肌梗死程度更轻(P<0.01);β3表达水平升高(P<0.01)。结论四氢生物蝶呤可以减少急性缺血再灌注损伤大鼠心肌梗死面积,改善心肌舒张功能,对大鼠急性缺血再灌注损伤具有保护作用,可能与激活eNOS活性、提高NO生成量和β3受体有关。 Objective To study protective effect of tetrahydrobiopterin against acute myocardial ischemia-reperfusion injury in rat, and discuss its mechanism. Methods Wistar rats were randomly divided into control, Sham, model, and tetrahydrobiopterin(5 and 10 mg/kg) groups, and each group had 10 rats. Rats were ligated the left anterior descending coronary artery and were established acute myocardial ischemia-reperfusion injury models. Rats in the control, Sham, and model groups were ig administrated with normal saline 2 mL, and rats in the tetrahydrobiopterin groups were ig administrated with tetrahydrobiopterin 5 and 10 mg/kg. The treatment were carried out once daily, and lasted for 14 d. Hemodynamic parameters, such as left ventricular diastolic maximum rate(-dp/dtmax), left ventricular end diastolic pressure(LVEDP), and left ventricular began to shrink to left ventricular pressure rise rate peak time(Tau) were determined by catheter method. Brain natriuretic peptide(BNP) activity in plasma was determined by ELISA method. Activity of eNOS and NO generation amounts were determined according to kit instructions. The area of myocardial infarction was determined by staining method, the degree of myocardial infarction was calculated, and the level of β3 was determined by immunohistochemistry method. Results Compared with the model group,-dp/dt_(max) in tetrahydrobiopterin(5 and 10 mg/kg) groups were significantly increased, LVEDP were significantly decreased, and Tau were significantly shortened, with significant difference between two groups(P〈 0.05,0.01). BNP activities in plasma were significantly decreased, activity of eNOS and NO generation amounts were significantly increased(P 〈0.01). Myocardial infarction areas were smaller, the degrees of myocardial infarction were more light, and β3 expressions were significantly higher in tetrahydrobiopterin(5 and 10 mg/kg) groups(P〈 0.01). Conclusion Tetrahydrobiopterin can reduce myocardial infarction area in rats with acute myocardial ischemia- reperfusion injury, improve cardiac diastolic function, and has protective effect against acute myocardial ischemia-reperfusion injury in rat, which may be related to activate eNOS activity, improve the NO generation amount and β3 receptors expression.
出处 《现代药物与临床》 CAS 2016年第6期752-756,共5页 Drugs & Clinic
基金 甘肃省自然科学基金资助项目(145RJZA174) 甘肃省青年科技基金计划资助项目(145RJYA257) 甘肃省卫生行业科研计划项目(GSWSKY-2014-33) 兰州市科学技术局项目(2012-1-31)
关键词 四氢生物蝶呤 急性心肌缺血再灌注损伤 血流动力学 心肌梗死程度 心肌舒张功能 保护作用 tetrahydrobiopterin acute myocardial ischemia-reperfusion injury hemodynamics myocardial infarction areas cardiac diastolic function protective effect
  • 相关文献

参考文献13

  • 1Wang Q, Yang M, Xu H, et al. Tetrahydrobiopterin improves endothelial function in cardiovascular disease: A systematic review [J]. Evid Based Complement Alternat Med, 2014, 2014: 1-7.
  • 2Baptista R, Jorge E, Sousa E, et al. B-type natriuretic peptide predicts long-term prognosis in a cohort of critically ill patients [J]. Heart Int, 2011, 6(2): e18.
  • 3Xu Z, Alloush J, Beck E, et al. A murine model of myocardial ischemia-reperfusion injury through ligation of the left anterior descending artery [J]. J Vis. Exp, 2014, 86: e51329.
  • 4Khan B V, Rahman S T, Haque T, et al. Vascular effects of nebivolol added to hydrochlorothiazide in African americans with hypertension and echocardiographic evidence of diastolic dysfunction: The nasaa study [J]. J Cardiovas Pharmacol Therap, 2012, 17(3): 291-297.
  • 5Wajima T, Shimizu S, Hiroi T, et al. Reduction of myocardial infarct size by tetrahydrobiopterin: Possible involvement of mitochondrial katp channels activation through nitric oxide production [J]. J Cardiovasc Pharmacol, 2006, 47(2): 243-249.
  • 6Hiroi T, Wajima T, Kaneko Y, et al. An important role of increase in tetrahydrobiopterin via H2O2-JAK2 signalling pathway in late phase of ischaemic preconditioning [J]. Exp Physiol, 2010, 95(5): 609-621.
  • 7Moens A L, Champion H C, Claeys M J, et al. High dose folic acid pre-treatment blunts cardiac dysfunction during ischemia coupled to maintenance of high energy phosphates and reduces post-reperfusion injury [J]. Circulation, 2008, 117(14): 1810-1819.
  • 8Takimoto E, Champion H C, Li M, et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load [J]. J Clin Invest, 2005, 115(5): 1221-1231.
  • 9Moens A L, Ketner E A, Takimoto E, et al. Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure [J]. J Mol Cell Cardiol, 2011, 51(4): 564-569.
  • 10Gauthier C, Tavernier G, Charpentier F, et al. Functional beta3-adrenoceptor in the human heart [J]. J Clin Invest, 1996, 98(2): 556-562.

同被引文献10

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部